glipizide Supplier - Hetero Drugs Limited

glipizide

Description : Seller Info :

Hetero Drugs Limited

Product Details :

Brandaldiab\r\ndigrin\r\ndipazide\r\nglibenese\r\nglibetin\r\nglican\r\nglide\r\nglidiab\r\nglipid9new zealand)\r\nglipizide extended-release tablets\r\ngluco-rite\r\nglucolip\r\nglucotrol(usa (va) fss prices)\r\nglucotrol xl(slovenia);(latvia);(lithuania);(usa (va) fss prices)\r\nglucozide\r\nglupitel\r\nglupizide\r\nglyde\r\nmelizide\r\nmetaglip\r\nmindiab(denmark);(norway);(sweden)\r\nminidab\r\nminidiab\r\nminodiab\r\nnapizide\r\nozidia\r\nsucrazide
Cas Number29094-61-9
Appearancecrystalline solid

Categories :

Pharmaceutical
About Suppliers :
Hetero Drugs Limited

Hetero Drugs Limited is a research based global pharmaceutical company focused on development, manufacturing and marketing of Active Pharmaceutical Ingredients (APIs), Intermediate Chemicals & Finished Dosages. Hetero product range include Adefovir Dipivoxil, Alfuzosin Hydrochloride, Azilsartan Medoxomil, Dexlansoprazole, Doxazosin Mesylate, Eprosartan Mesylate, Esomeprazole Sodium, Fingolimod Hydrochloride, Fosinopril Sodium, Pantoprazole Sodium etc. Hetero  establishment in 1993, Hetero showed a tradition of excellence and deep sense of commitment in developing cost effective processes to offer wide range of affordable drugs. Hetero is building on the strengths of vertical integration in discovery research, process chemistry, API manufacturing, formulation development and commercialization.

Hetero is a leading international supplier with a rich portfolio of over 200 products from wide range of therapeutic categories both in active pharmaceutical ingredients and finished dosages. Hetero’s manufacturing facilities are cGMP compliant meeting global standards in terms of infrastructure and systems. Majority of them are approved by the various regulatory authorities of USFDA, WHO-Geneva, Australian TGA, Spanish agency of medicines & health care products, ANVISA-Brazil, IDA-Netherlands etc.